| Suppression of STING associated with LKB1 loss in KRAS-driven lung cancer S Kitajima, E Ivanova, S Guo, R Yoshida, M Campisi, SK Sundararaman, ... Cancer discovery 9 (1), 34-45, 2019 | 328 | 2019 |
| Tumor-derived cGAMP regulates activation of the vasculature M Campisi, SK Sundararaman, SE Shelton, EH Knelson, NR Mahadevan, ... Frontiers in Immunology 11, 2090, 2020 | 47 | 2020 |
| Frequent somatic TET2 mutations in chronic NK-LGL leukemia with distinct patterns of cytopenias TL Olson, HJ Cheon, JC Xing, KC Olson, U Paila, CE Hamele, ... Blood, The Journal of the American Society of Hematology 138 (8), 662-673, 2021 | 38 | 2021 |
| MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer S Kitajima, T Tani, BF Springer, M Campisi, T Osaki, K Haratani, M Chen, ... Cancer Cell 40 (10), 1128-1144. e8, 2022 | 30 | 2022 |
| A robust vasculogenic microfluidic model using human immortalized endothelial cells and Thy1 positive fibroblasts Z Wan, S Zhang, AX Zhong, SE Shelton, M Campisi, SK Sundararaman, ... Biomaterials 276, 121032, 2021 | 29 | 2021 |
| Suppression of STING associated with LKB1 loss in KRAS-Driven lung Cancer. Cancer Discovery. 2019; 9: 34–45. doi: 10.1158/2159-8290 S Kitajima, E Ivanova, S Guo, R Yoshida, M Campisi, SK Sundararaman, ... CD-18-0689.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 21 | |
| Tumor cGAMP awakens the natural killers SK Sundararaman, DA Barbie Immunity 49 (4), 585-587, 2018 | 19 | 2018 |
| Coronary computed tomography angiography demonstrates a high burden of coronary artery disease despite low‐risk nuclear studies in pre–liver transplant evaluation AI Löffler, JA Gonzalez, SK Sundararaman, RC Mathew, PT Norton, ... Liver Transplantation 26 (11), 1398-1408, 2020 | 18* | 2020 |
| MET-induced CD73 restrains STING-mediated immunogenicity of EGFR-mutant lung cancer R Yoshida, M Saigi, T Tani, BF Springer, H Shibata, S Kitajima, ... Cancer research 82 (21), 4079-4092, 2022 | 11 | 2022 |
| Suppression of STING associated with LKB1 loss in KRAS-driven lung cancer. Cancer Discov 9 (1): 34–45 S Kitajima, E Ivanova, S Guo, R Yoshida, M Campisi, SK Sundararaman, ... | 5 | 2019 |
| EGFR exon 19 insertion EGFR-K745_E746insIPVAIK and others with rare XPVAIK amino-acid insertions: preclinical and clinical characterization of the favorable therapeutic window … W Shaffer, IS Kobayashi, D Sentana-Lledo, S Sundararaman, MD Lee, ... Lung Cancer, 107250, 2023 | 1 | 2023 |
| Use of heparin to promote type 1 interferon signaling S Sundararaman, E Knelson, S Kitajima, D Barbie, S Han US Patent App. 17/638,150, 2022 | 1 | 2022 |
| Tumor-vascular interactions promote STING-driven inflammation in the tumor microenvironment M Campisi, SK Sundararaman, S Kitajima, V Chiono, RD Kamm, ... Cancer Research 79 (13_Supplement), 958-958, 2019 | 1 | 2019 |
| Thrombosis and Intracranial Hemorrhage in Patients with Metastatic Brain Cancer Treated with Immune Checkpoint Inhibitors Versus Chemotherapy MJF Turizo, SK Sundararaman, L Dodge, EJ Miller, EJ Uhlmann, ... Blood 142, 2658, 2023 | | 2023 |
| PB0960 Thrombosis and Intracranial Hemorrhage in Patients with Metastatic Brain Tumors Treated with Immune Checkpoint Inhibitors S Sundararaman, L Dodge, E Miller, E Uhlmann, R Patell Research and Practice in Thrombosis and Haemostasis 7, 101739, 2023 | | 2023 |
| Obesity, dyslipidemia, and diabetes as determinants of response to immune checkpoint inhibitors in non-small cell lung cancer. SA Osataphan, M Awidi, YJ Jan, S Sundararaman, H Viray, ... Journal of Clinical Oncology 41 (16_suppl), e21125-e21125, 2023 | | 2023 |
| VASCULARIZED MICRO-PHYSIOLOGICAL MODELS FOR STUDYING MULTICELLULAR-VASCULAR INTERACTIONS AND NANOCARRIER DRUG TRANSPORT THROUGH MICROFLUIDIC TECHNOLOGIES M Campisi, T Osaki, S Shelton, S Sundararaman, S Lee, C Mattu, ... TISSUE ENGINEERING PART A 28, S243-S243, 2022 | | 2022 |
| Microphysiological systems for modelling microvasculature and multicellular-vascular interactions using microfluidic technology M Campisi, T Osaki, S Shelton, S Sundararaman, S Lee, C Mattu, ... Termis Virtual seminar series, 2020 | | 2020 |
| P2. 04-23 Tumor-Stroma Interactions Promote cGAS-STING Driven Inflammation in Lung Tumor Microenvironment M Campisi, S Sundararaman, S Kitajima, I Canadas, V Chiono, R Kamm, ... Journal of Thoracic Oncology 14 (10), S717, 2019 | | 2019 |
